Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phenylbutyrate Development for Huntington's Disease (PHEND-HD): A Multi-Center, Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up to Determine the Safety and Tolerability of Phenylbutyrate in Subjects With Huntington's Disease

NCT00212316 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT00212316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00212316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phenylbutyrate Development for Huntington's Disease (PHEND-HD): A Multi-Center, Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up to Determine the Safety and Tolerability of Phenylbutyrate in Subjects With Huntington's Disease
Lead sponsor
University of Rochester
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2005
Completion date
June 30, 2006
Enrollment
60
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

huntington's disease